Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Stable gastric pentadecapeptide BPC 157 heals established vesicovaginal fistula and counteracts stone formation in rats (CROSBI ID 302629)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Rašić, Domagoj ; Zenko Sever, Anita ; Rašić, Fran ; Štrbe, Sanja ; Rašić, Žarko ; Đuzel, Antonia ; Duplančić, Božidar ; Boban Blagaić, Alenka ; Škrtić, Anita ; Seiwerth, Sven et al. Stable gastric pentadecapeptide BPC 157 heals established vesicovaginal fistula and counteracts stone formation in rats // Biomedicines, 9 (2021), 9; 1206, 18. doi: 10.3390/biomedicines9091206

Podaci o odgovornosti

Rašić, Domagoj ; Zenko Sever, Anita ; Rašić, Fran ; Štrbe, Sanja ; Rašić, Žarko ; Đuzel, Antonia ; Duplančić, Božidar ; Boban Blagaić, Alenka ; Škrtić, Anita ; Seiwerth, Sven ; Sikirić, Predrag ; Sever, Marko

engleski

Stable gastric pentadecapeptide BPC 157 heals established vesicovaginal fistula and counteracts stone formation in rats

With the stable gastric pentadecapeptide BPC 157 therapy known to heal various both external and internal rat fistulas, we attempt to approach vesicovaginal fistula, continuous urine leaking through vagina, bladder stones, and a possible therapy solution among rats with well-formed 2 week-fistulas (vaginal/vesical 4 mm large defects) started with delayed therapy. Subsequent control fistula course (the subsequent 1, 2, 4, and 6 weeks) since beginning revealed the failed healing, fistula leaking, adhesions, urinary leaking through vagina, failed epithelization, collagenization, granulation tissue and neovascularization, increased inflammation, and necrosis. Thereby, the later intervals revealed the persistent inability to sustain even minimal volume, vesical, and vaginal defects and stone formation at the end of the experiment (fistula- time day 56). BPC 157 therapy (10 µg/kg, 10 ng/kg, intraperitoneally once time daily or perorally in drinking water until sacrifice) was initiated with a considerable delay (at 2 weeks after fistula formation). Already within 1 week therapy, all BPC 157 regimens stopped urinary leaking through vagina, reversed the otherwise resistant poor healing course to the increased epithelization, collagenization, granulation tissue and neovascularization, decreased inflammation, and decreased necrosis. Thereby, at later intervals, all BPC 157 rats exhibited a five times larger volume that can be sustained before leaking as in healthy, vesical, and vaginal defects completely closed and no stone formation. Thus, macro/microscopic and functional recovery, and counteracted stone formation. Concluding, BPC 157 therapy's beneficial effects resulted in healing and no stone formation, with µg- and ng-regimens, either given daily perorally in drinking water or intraperitoneally.

rats ; stable gastric pentadecapeptide BPC 157 ; stone formation ; vesicovaginal fistula

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

9 (9)

2021.

1206

18

objavljeno

2227-9059

10.3390/biomedicines9091206

Trošak objave rada u otvorenom pristupu

Povezanost rada

Kliničke medicinske znanosti, Temeljne medicinske znanosti

Poveznice
Indeksiranost